AlphaCrest Capital Management LLC
- SEC CIK
- 0001633256
- Latest filing
- Jan 27, 2023
RARE holding history
Ultragenyx Pharmaceutical Inc. in every 13F filed by AlphaCrest Capital Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RARE overviewAll 13F holders of RAREFull Q4 2022 holdings
- Shares (Q4 2022)
- 0
- Sold out in Q4 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2022 | 0 | $0 | 0.0% | −24,383−100.0% | Sold out | Holders |
| Q3 2022 | 24,383 | $1.01M | 0.1% | +24,383 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −7,015−100.0% | Sold out | Holders |
| Q1 2022 | 7,015 | $509.0K | <0.1% | +3,725+113.2% | Added | Holders |
| Q4 2021 | 3,290 | $277.0K | <0.1% | −3,158−49.0% | Reduced | Holders |
| Q3 2021 | 6,448 | $582.0K | <0.1% | −6,353−49.6% | Reduced | Holders |
| Q2 2021 | 12,801 | $1.22M | 0.1% | +12,801 | New | Holders |